SIMOLADAGENE AUTOTEMCEL

UNII:	MOD3RG31RS
Formula:
Preferred Substance Name:	SIMOLADAGENE AUTOTEMCEL
GSRS Full Record:	MOD3RG31RS i

CELL BASED DRUG PRODUCT CONSISTING OF CELLS THAT HAVE BEEN GENETICALLY MODIFIED EX VIVO. IT INCLUDES AUTOLOGOUS CD34+ HEMATOPOIETIC STEM CELLS (HSCS) FROM SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY (ADA-SCID) SUBJECTS TRANSDUCED EX VIVO WITH AN EF1AS LENTIVIRAL VECTOR (LV) THAT ENCODES FOR THE HUMAN ADENOSINE DEAMINASE (ADA) COMPLEMENTARY DEOXYRIBONUCLEIC ACID (CDNA) (EFS-ADA LV)
OTL-101
SIMOLADAGENE AUTOTEMCEL [INN]
SIMOLADAGENE AUTOTEMCEL [USAN]
SIMOLADAGENE AUTOTEMCEL [WHO-DD]

Inxight Drugs
i
ITIS
i
NCBI Taxonomy
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SIMOLADAGENE AUTOTEMCEL

Synonyms and Mappings

Resources